U.S. Court of Appeals for the Federal Circuit
Ucb, Inc. v. Actavis Laboratories Ut, Inc.
This writing
- Type
- Opinion
- Filed
- April 12, 2023
- Case
- Ucb, Inc. v. Actavis Laboratories Ut, Inc.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 21-1924 Document: 65 Page: 1 Filed: 04/12/2023 United States Court of Appeals for the Federal Circuit ______________________ UCB, INC., UCB PHARMA GMBH, LTS LOHMANN THERAPIE-SYSTEME AG, Plaintiffs-Appellants v. ACTAVIS LABORATORIES UT, INC., Defendant-Appellee ______________________ 2021-1924…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.